The present invention describes the determination of the prognostic impact of hERG1 potassium channels along with other hypoxia-related biomolecular parameters, in patients who underwent radical surgery with curative intent for non metastatic CRC.
申请公布号
EP2742357(A1)
申请公布日期
2014.06.18
申请号
EP20120756392
申请日期
2012.08.10
申请人
UNIVERSITA' DEGLI STUDI DI FIRENZE
发明人
ARCANGELI, ANNAROSA;CROCIANI, OLIVIA;LASTRAIOLI, ELENA;ROMOLI, RAFFAELLA;BONI, LUCA;DI COSTANZO, FRANCESCO
